With a federal law, the health insurance contributions are to be kept stable, but resistance is growing. An open letter from a pharmaceutical company from Heppenheim comes to the floor. The concerns: Especially in children's medicines, there may be gaps in care.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
With a federal law, the health insurance contributions are to be kept stable, but resistance is growing. An open letter from a pharmaceutical company from Heppenheim comes to the floor. The concerns: Especially in children's medicines, there may be gaps in care.